Royalty Pharma plc (NASDAQ:RPRX) currently has a daily average trading volume of 4.89M but it saw 4182512 shares traded in last market. With a market cap of 18.46B USD, the company’s current market price of $32.83 came falling about -0.79 while comparing to the previous closing price of $33.09. In past 52 weeks, the stock remained buoying in the range of price level as high as $34.31 and as low as $24.05.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Morgan Stanley which initiated the stock as “Overweight” in its note to investors issued on May 16, 2025, recommending a price target of $51 for it. UBS downgraded its recommendation for the stock as a “Neutral” from “Buy” on June 03, 2024 while assigning a price target of $28. UBS issued its recommendations for the stock as it resumed the price target for the stock is $47.
Over the week, RPRX’s stock price is moving 1.67% up while it is 1.99% when we observe its performance for the past one month. Year-to-date it is 28.69% up and over the past year, the stock is showing an upside performance of 20.39%.
Currently, Royalty Pharma plc’s total number of outstanding shares is 425.59M with 8.80% of that held by the insiders while 79.25% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 8.21% and return on equity (ROE) at 16.57%. It has a price to earnings ratio (P/E ratio) of 13.39 while having a 6.53 of forward P/E ratio. Stock’s beta reads 0.48. Stock has a price to book (P/B) ratio of 2.09 while price to sale or P/S ratio amounts to 8.15. Its return on asset (ROA) is 6.48% on average.
